JPS6137247A - Instrument made of plasticizer migration material and its production - Google Patents

Instrument made of plasticizer migration material and its production

Info

Publication number
JPS6137247A
JPS6137247A JP16133284A JP16133284A JPS6137247A JP S6137247 A JPS6137247 A JP S6137247A JP 16133284 A JP16133284 A JP 16133284A JP 16133284 A JP16133284 A JP 16133284A JP S6137247 A JPS6137247 A JP S6137247A
Authority
JP
Japan
Prior art keywords
adhesive
plasticizer
bonded
parts
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16133284A
Other languages
Japanese (ja)
Other versions
JPH044939B2 (en
Inventor
孝夫 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP16133284A priority Critical patent/JPS6137247A/en
Publication of JPS6137247A publication Critical patent/JPS6137247A/en
Publication of JPH044939B2 publication Critical patent/JPH044939B2/ja
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00General aspects of processes or apparatus for joining preformed parts
    • B29C66/70General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
    • B29C66/71General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the composition of the plastics material of the parts to be joined

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 ■ 発明の背景 発明の分野 本発明は、溶剤を使用することなく接着された接着部を
有する医療用具およびその製造方法ならびにその接着に
使用する接着剤に関するものである。
DETAILED DESCRIPTION OF THE INVENTION 1. Background of the Invention Field of the Invention The present invention relates to a medical device having a bonded portion bonded without using a solvent, a method for manufacturing the same, and an adhesive used for bonding the device.

従来技術とその問題点 従来、塩化ビニル樹脂製医療用具の製造過程においては
、各構造部品同志の接着をTHF、シフトヘキサノン等
の揮発性溶剤を主成分とする接着剤により行っていた。
BACKGROUND ART Conventionally, in the manufacturing process of medical devices made of vinyl chloride resin, structural parts have been bonded together using an adhesive containing a volatile solvent such as THF or shifted hexanone as a main component.

しかしながら残留溶剤が医療用具の使用時に、薬液ある
いは体液を汚染する危険性があった。
However, there is a risk that the residual solvent may contaminate medical fluids or body fluids when the medical device is used.

また、その製造段階において、溶剤による製造環境の汚
染もあり、これに対する十分な対応が必要であった・ また、溶剤を使用しない接着方法としては、エポキシ樹
脂、UV接着剤、ホットメルト系接着剤等を使用する方
法があるが、塩化ビニル樹脂製医療用具に使用した場合
、十分な接着強度が得られず、また安全性、作業性の点
でも問題があった。
In addition, during the manufacturing stage, the manufacturing environment was contaminated by solvents, and sufficient measures needed to be taken to prevent this.In addition, adhesive methods that do not use solvents include epoxy resins, UV adhesives, and hot melt adhesives. However, when used for medical devices made of vinyl chloride resin, sufficient adhesive strength could not be obtained, and there were also problems in terms of safety and workability.

II  発明の目的 本発明の目的は、上記先行技術の問題点を解決しようと
するもので、揮発性溶剤を含まない接着剤を用いて接続
部を接着するための接着剤、およびこの接着剤を用いて
接続部を接着する医療用具の製造方法ならびに上記接着
剤を用いて接着された接続部を有する医療用具を提供し
、これにより接着強度に優れ、作業性もよく、使用時に
残留溶剤により薬液や体液の汚染のおそれ、あるいは製
品性能への悪影響を除去しようとするものである。
II. OBJECTS OF THE INVENTION The object of the present invention is to solve the problems of the prior art described above, and to provide an adhesive for bonding connection parts using an adhesive that does not contain volatile solvents, and an adhesive that uses this adhesive. The present invention provides a method for manufacturing a medical device in which the connection part is bonded using the above-mentioned adhesive, and a medical device having the connection part bonded using the above-mentioned adhesive, which has excellent adhesive strength and good workability. The aim is to eliminate the risk of contamination of chemicals and body fluids, or any negative impact on product performance.

■ 発明の具体的構成 上記目的は、以下に述べる本発明により達成される。■Specific structure of the invention The above object is achieved by the present invention described below.

すなわち、発明の第1の態様によれば、少なくとも1つ
の接着部を有する可塑剤移行性材料製具であって、該可
塑剤移行性材料製具中の可塑剤濃度が勾配を示し、その
濃度は接着部から遠くなる程、低いことを特徴とする可
塑剤移行性材料製具が提供される。
That is, according to a first aspect of the invention, there is provided a plasticizer-migrating material device having at least one adhesive portion, wherein the plasticizer concentration in the plasticizer-migrating material device exhibits a gradient, and the concentration of plasticizer in the plasticizer-migrating material device exhibits a gradient. Provided is a plasticizer-migration material tool characterized in that the distance from the adhesive portion is lower, the lower the value is.

本発明の第2の態様によれば、少なくとも1つの接続部
を有し、該可塑剤移行性材料製具中の可塑剤濃度が勾配
を示し、その濃度は接着部から遠くなる程、低いもので
ある可塑剤移行性材料製具を製造するに際し、接着すべ
き部分間に可塑剤100重量部中に、0.5〜10重量
部の塩化ビニル樹脂を溶解してなる接着剤を介在さしめ
、該接着剤を硬化させて接着することを特徴とする可塑
剤移行性材料製具の製造方法が提供される。
According to a second aspect of the present invention, the plasticizer concentration in the plasticizer-migratable material device having at least one connection portion exhibits a gradient, and the concentration is lower as the distance from the adhesive portion increases. When manufacturing a plasticizer migration material tool, an adhesive made by dissolving 0.5 to 10 parts by weight of vinyl chloride resin in 100 parts by weight of a plasticizer is interposed between the parts to be bonded. , there is provided a method for manufacturing a plasticizer-migration material article, which is characterized in that the adhesive is cured and bonded.

以下、本発明を更に詳細に説明する。The present invention will be explained in more detail below.

本発明において使用される接着剤は、ポリ塩化ビニル樹
脂を可塑剤に溶解したものであって、溶解前の固形分と
して0.5〜10wt%含有せしめる必要がある。塩化
ビニル樹脂量が0.5 wt%未満では十分な接着力お
よび接着の安定性が得られず、また10wt%を超える
と、粘度が高くなり、加熱下でもゲル状となり、作業性
を著しく損なう結果となる。
The adhesive used in the present invention is a polyvinyl chloride resin dissolved in a plasticizer, and must contain 0.5 to 10 wt% of solid content before dissolution. If the amount of vinyl chloride resin is less than 0.5 wt%, sufficient adhesive strength and adhesion stability cannot be obtained, and if it exceeds 10 wt%, the viscosity becomes high and becomes gel-like even under heating, significantly impairing workability. result.

可塑剤としては、ディオクチルフタレート(DOP)、
  ブチルベンジルフタレート(BBP)、エポキシ化
大豆油、デイオクチルセバケー) (DOS)、ジシク
ロヘキシル(DCHP)、ジヘプチル(DHP)等の塩
化ビニル樹脂の可塑剤として使用できるものであれば何
でもよい。
As a plasticizer, dioctyl phthalate (DOP),
Anything that can be used as a plasticizer for vinyl chloride resin may be used, such as butyl benzyl phthalate (BBP), epoxidized soybean oil, dioctyl sebacate (DOS), dicyclohexyl (DCHP), diheptyl (DHP), etc.

この接着剤の作製および作業上は、粒径の小さいベース
トレジン(塩化ビニル樹脂の可塑剤への分散物)を使用
し、このペーストレジンの分散液を作製しておき、接着
直前に加熱溶解して使用するのが良い。分散液は約13
5℃に加熱すると塩化ビニル樹脂の粒子が溶けて溶解液
となる。この接着剤は、溶解後冷却して再び塩化ビニル
樹脂が析出するこはなく、加熱後冷却すると寒天状にな
り、保存可能で、使用時には再加熱すればよい。
In manufacturing and working with this adhesive, a base resin (a dispersion of vinyl chloride resin in a plasticizer) with a small particle size is used, a dispersion of this paste resin is prepared, and it is heated and dissolved immediately before bonding. It is good to use it. The dispersion is about 13
When heated to 5°C, the vinyl chloride resin particles melt to form a solution. When this adhesive is cooled after being melted, the vinyl chloride resin does not precipitate again, and when it is heated and then cooled, it becomes agar-like and can be stored, and only needs to be reheated before use.

このようにして得た接着剤は、必要によりジベンジリデ
ン−D−ソルビトール等のゲル化促進剤を加えることが
できる。このゲル化促進剤の配合により、接着部のゲル
化が促進され、この接着剤の仮硬化時間(加熱処理前の
低い接着力を得るまでの時間)を短縮することができる
The adhesive obtained in this way may contain a gelation accelerator such as dibenzylidene-D-sorbitol, if necessary. By adding this gelation accelerator, gelation of the adhesive part is promoted, and the temporary curing time of this adhesive (the time required to obtain low adhesive strength before heat treatment) can be shortened.

この接着剤を使用する際には、常温でゲル状もしくは高
粘度のものを加熱することによって接着剤の流動性を増
し、接着債所への塗布性を増させ、接着作業性および接
着安定性を向上させる。
When using this adhesive, heating the gel-like or high-viscosity adhesive at room temperature increases the fluidity of the adhesive, increases its applicability to the adhesive points, improves adhesive workability and adhesive stability. improve.

この接着剤が使用可能な被接着材料は、可塑剤移行性材
料すなわち上述した接着剤中の可塑剤が上記材料中へ拡
散もしくは分散して移行可能なものに限られる。このよ
うな可塑剤移行性材料としては、ポリ塩化ビニル、ポリ
カーボネート、アクリレート、メタクリレート等を挙げ
るとこができる。従って、本発明の医療用器の接続部は
このような材料で構成されていなければならない。また
、そのような材料で構成されていれば、その材料の種類
は限定されない。
The materials to be adhered to which this adhesive can be used are limited to plasticizer migration materials, that is, materials to which the plasticizer in the above-mentioned adhesive can be diffused or dispersed and migrated into the material. Examples of such plasticizer migration materials include polyvinyl chloride, polycarbonate, acrylate, and methacrylate. Therefore, the connecting portion of the medical device of the present invention must be made of such a material. Moreover, the type of material is not limited as long as it is made of such a material.

次に、本発明の接着剤を用いて接続部の接着を行って、
医療用具を製造する方法につき説明する。
Next, the connecting portion is bonded using the adhesive of the present invention,
A method for manufacturing medical devices will be explained.

本発明で用いる接着剤は、接着部の形状によらず有効に
使用できるがJ°後処理(加熱処理)の行いやすい点で
、管状部材同志の接着に対して特に有効である。従って
、以下の説明は、医療用具の内管状部材同志の接着につ
いて代表的に行う。
The adhesive used in the present invention can be used effectively regardless of the shape of the bonded part, but it is particularly effective for bonding tubular members together because it is easy to perform J° post-treatment (heat treatment). Therefore, the following description will be made representatively of adhesion between inner tubular members of a medical device.

第1図に管状部材同志の接着工程を示す。FIG. 1 shows the process of bonding tubular members together.

第1a図に示すようなチューブlの接着すべき端部に、
上述した本発明の接着剤2を加温して液状としたものを
被着させ(第1b図参照)、これを接着剤がゲル化する
以前に第1C図に示す接続すべきもう一方のチューブ3
の端部に押入してチューブ1および3の接続部4間に接
着剤2を介在させる(第1d図参照)。
At the end of the tube l to be glued, as shown in FIG. 1a,
The adhesive 2 of the present invention described above is heated and made into a liquid state (see Fig. 1b), and before the adhesive gels, it is applied to the other tube to be connected as shown in Fig. 1C. 3
The adhesive 2 is inserted between the connecting portion 4 of the tubes 1 and 3 by pressing the adhesive 2 into the end of the tube (see FIG. 1d).

この時、接着剤の温度低下により急速にゲル化し、チュ
ーブ1,3間にある程度の接着力を与える。また、この
現象により接着剤がチューブの接着しない部分への転写
が防止される。
At this time, the temperature of the adhesive decreases, causing it to rapidly gel, providing a certain degree of adhesive force between the tubes 1 and 3. This phenomenon also prevents the adhesive from transferring to non-adhesive portions of the tube.

本発明の接着剤を使用して、接着部に必要強度を与える
ためには、必要強度に応じ、後処理として加熱処理を行
う必要がある。この加熱処理により接着前の硬化を迅速
に行うことができる。
In order to provide the required strength to the bonded portion using the adhesive of the present invention, it is necessary to perform a heat treatment as a post-treatment depending on the required strength. This heat treatment allows rapid curing before bonding.

第1d図に示すように、チューブ同志が挿入接合される
状態は常温的20℃で行われる。従って、この後に施さ
れる加熱は常温以上で接着部材に悪影響を与えない温度
以下で、要求される接着強度に応じて少なくとも1回の
加熱処理を行うことができる。最初の熱処理としてはプ
ラスチックの変形の少ない温度としてオーブンによる加
熱(60°C程度)が好ましい。
As shown in FIG. 1d, the tubes are inserted and joined together at room temperature of 20°C. Therefore, the heating performed thereafter is at a temperature higher than room temperature and lower than a temperature that does not adversely affect the adhesive member, and at least one heat treatment can be performed depending on the required adhesive strength. As the first heat treatment, heating in an oven (approximately 60° C.) is preferred as the temperature is such that the plastic is less deformed.

さらに加熱処理する場合は、オートクレーブ内における
加熱処理(120℃程度)が好ましい。
In the case of further heat treatment, heat treatment in an autoclave (approximately 120° C.) is preferred.

この例示的温度は本発明における加熱処理の臨界的温度
ではないが、代表的に上記2段階の加熱処理を行う例に
ついて加熱処理工程を説明する。
Although this exemplary temperature is not a critical temperature for the heat treatment in the present invention, the heat treatment process will be described with reference to an example in which the above two-stage heat treatment is typically performed.

例えば、接着部の必要強度が小さい時には、加熱処理を
しなくても、室温で長時間(接着部材料、形状、あるい
は接着剤の配合などによっても異なるが、一般に24時
間程度でよい)放置することによって接着剤が硬化する
。さらに強度を上げるためには、その必要強度に応じて
、加熱条件を変えればよい。
For example, if the required strength of the adhesive part is low, leave it at room temperature for a long time (generally about 24 hours is sufficient, although it varies depending on the adhesive part material, shape, and adhesive composition) without heat treatment. This will cause the adhesive to harden. In order to further increase the strength, the heating conditions may be changed depending on the required strength.

前述のように、接着部に接着剤を塗布してゲル化させた
時には、1〜2Kgの接着力が得られる。
As mentioned above, when the adhesive is applied to the adhesive portion and gelled, an adhesive force of 1 to 2 kg can be obtained.

後の実施例にも示すように、これをオーブン処理(60
℃、3時間)する場合には、接着強度は約4Kgに、さ
らにオートクレーブ処理(120°Cl2O分)する場
合には、接着強度は溶剤による接着強度よりも強く、約
8Kgにも到達する。これはプラスチック(接着部材)
が溶剤による劣化を受けない為である。
As shown in the later examples, this was subjected to oven treatment (60
℃ for 3 hours), the adhesive strength is approximately 4 kg, and when autoclave treatment (120° C. Cl2O min) is performed, the adhesive strength is stronger than that obtained with a solvent, and reaches approximately 8 kg. This is plastic (adhesive material)
This is because it is not subject to deterioration due to solvents.

本発明で用いる接着剤と、一般にプラスチゾルまたはペ
ーストレジンと称される接着剤の差異は次のようなもの
である。
The differences between the adhesive used in the present invention and the adhesive generally referred to as plastisol or paste resin are as follows.

本発明で用いる接着剤は、少なくとも接着時において塩
化ビニル樹脂が可塑剤中に溶けた溶液であるのに対し、
プラスチゾルまたはペーストレジンは分散液である。こ
の為、可塑剤が医療用具の接着部に分散吸収された後の
接着剤層は、前者が塩化ビニル樹脂の分子のからみ合っ
た強固なものになるのに対し、後者は高温(140℃以
上)で溶融しない限り可塑剤が浸入した粒子の塊であり
、凝集力の弱いものとなる。一般にプラスチ・ンク製の
部品は高温に弱く、できるかぎり低い温度で接着処理で
きる方が好ましいので、上記ペーストレジン等よりも本
発明に係る接着剤の方が優れている。
The adhesive used in the present invention is a solution in which vinyl chloride resin is dissolved in a plasticizer, at least during bonding.
Plastisol or paste resins are dispersions. For this reason, after the plasticizer is dispersed and absorbed into the adhesive part of the medical device, the adhesive layer in the former becomes a strong one consisting of entangled vinyl chloride resin molecules, while the latter becomes a strong adhesive layer at high temperatures (over 140 degrees Celsius). ) unless it is melted, it will be a lump of particles infiltrated with plasticizer and will have weak cohesive force. In general, parts made of plastic are sensitive to high temperatures, and it is preferable to bond them at as low a temperature as possible, so the adhesive according to the present invention is superior to the above-mentioned paste resin and the like.

加熱により接着部の強度が増大するのは、加熱により可
塑剤が接着すべき部材中へさらに移行し、接着部におけ
る可塑剤の儂度勾配が次第に小さくなり、均質化するた
めと考えられる。
The reason why the strength of the bonded portion increases due to heating is thought to be that the plasticizer further migrates into the members to be bonded due to heating, and the gradient of plasticizer in the bonded portion gradually becomes smaller and becomes homogenized.

■ 実施例 第2図に示す血液バッグにおいて、採血チューブ10と
カバーチューブ11ならび(こ連結チューブ12とY字
管13についての接着を代表例として以下に具体的に説
明する。なお、連結すべき上記部品は、塩化ビニル10
0重量部に対し、DOPを70重量部および適量の安定
剤、滑剤等を配合してなる組成のものである。接着され
た後の構造を第3図に部分断面で示す。
■Example In the blood bag shown in FIG. The above parts are made of vinyl chloride 10
It has a composition of 0 parts by weight, 70 parts by weight of DOP, and appropriate amounts of stabilizers, lubricants, etc. The structure after bonding is shown in partial cross section in FIG.

接合部寸法:採血および連結チューブ(内径×外径) 
3 、 OX4 、4(mm)Y字管(内径X外径) 4 、 IX6 、5(mm) カバーチューブ(内径×外径) 4、IX6.5(mm) 接合長さ      6 (m+w) (接着剤の調整および塗布) 乳鉢に配合例に示す配合剤を取り、乳棒にて、塊のなく
なるまで十分に練る。
Joint dimensions: Blood collection and connection tube (inner diameter x outer diameter)
3, OX4, 4 (mm) Y-shaped tube (inner diameter x outer diameter) 4, IX6, 5 (mm) Cover tube (inner diameter x outer diameter) 4, IX6.5 (mm) Joining length 6 (m+w) (adhesion Preparation and Application of Agent) Place the formulation shown in the formulation example in a mortar and knead thoroughly with a pestle until there are no lumps.

配合例 ベーストレジン            5(商品名:
ビニ力P440、三菱モンサント社製)DOP    
           100ゲル化剤       
        3(商品名ニゲルマスター0P−0’
5 、新日本理科社製) 接着剤は上記の如くして調整できる、そこで、使用する
可塑剤に応して適当な塗布温度を調べたところ、第4図
に示すようになった。すなわち、 0−0  の範囲が
好適な温度範囲であり、これより低い温度では塩化ビニ
ル樹脂の溶解性が小さく、高い温度では可塑剤の蒸散が
大となって好ましくない。第4図かられかるように、本
発明の実施例の接着剤は約120〜130℃で使用すれ
ばよい。
Formulation example Base Torezin 5 (Product name:
Viniki P440, manufactured by Mitsubishi Monsanto) DOP
100 gelling agent
3 (Product name Nigel Master 0P-0'
5, manufactured by Shin Nippon Rika Co., Ltd.) The adhesive can be adjusted as described above.The appropriate application temperature was investigated depending on the plasticizer used, and the result was as shown in FIG. That is, a temperature range of 0-0 is a suitable temperature range, and at lower temperatures, the solubility of the vinyl chloride resin is low, and at higher temperatures, evaporation of the plasticizer increases, which is not preferred. As can be seen from FIG. 4, the adhesive of the embodiment of the present invention may be used at about 120-130°C.

可塑剤の種類および塩化ビニル樹脂の配合量を変えた種
々の接着剤を調整し、これを第1図で説明したようにし
て、約130 ’Cで接着剤を塗布し、第3図に示す接
着部を得た。
Various adhesives with different types of plasticizers and amounts of vinyl chloride resin were prepared, and the adhesives were applied at about 130'C as explained in Figure 1, as shown in Figure 3. A bonded part was obtained.

上記種々の接着剤において、接着直後で接着部の接着強
度は平均で1.2Kgであり、24時間放置したものに
ついては平均で1.9Kgであった。これでは非常に接
着強度が小さすぎるため、次の2段階に亘る加熱処理を
行った。
In the various adhesives mentioned above, the adhesive strength of the bonded portion immediately after bonding was 1.2 kg on average, and when left for 24 hours, it was 1.9 kg on average. Since the adhesive strength was too low, the following two steps of heat treatment were performed.

第1段階  常温仮接着   20’C第2段階  オ
ーブン    60℃、3時間第3段階  オートクレ
ーブ 120℃、20分間 このような加熱処理工程を経た後の接着部の接着強度の
変化について、代表例を、カバーチューブの接着性につ
いては第5図および第6図に、Y字管の接着性について
は第7図およぶ第8図にそれぞれ示す。これらの図面に
おいて、滅菌前とはオーブン処理を経たものを意味し、
滅菌後とはオートクレーブ滅菌処理を経たものを意味す
る。
1st stage Temporary adhesion at room temperature 20'C 2nd stage Oven 60°C, 3 hours 3rd stage Autoclave 120°C, 20 minutes Regarding the change in adhesive strength of the bonded part after such a heat treatment process, typical examples are as follows: The adhesion of the cover tube is shown in FIGS. 5 and 6, and the adhesion of the Y-tube is shown in FIGS. 7 and 8, respectively. In these drawings, "before sterilization" means after oven treatment;
"After sterilization" means something that has undergone autoclave sterilization.

これらの試験結果を示す図かられかるように、接着部の
接着強度は接着したままのものよりも、加熱処理によっ
て飛躍的に増大することが明白で、本発明の効果が顕著
である。
As can be seen from the graphs showing these test results, it is clear that the adhesive strength of the bonded portion is dramatically increased by heat treatment compared to that of the bonded portion as it is, and the effect of the present invention is remarkable.

(接着強度の試験) 上記の接着強度は下記のようにして測定したものである
(Test of Adhesive Strength) The above adhesive strength was measured as follows.

接合部より少し離れた場所をストログラフのチャックに
挟み、管の中心軸方向に引っ張る時の強度を測定する(
引っ張りスピード200 m+i/m1n)。
Place the part slightly away from the joint between the strograph chucks and measure the strength when pulling in the direction of the central axis of the tube (
Pulling speed 200 m+i/m1n).

■ 発明の効果 本発明においては、THF、シクロヘキサン等の揮発性
溶剤を主成分とする接着剤を用いない。従って、この溶
剤の一部が塩化ビニル樹脂などの医療用具構成材料中に
浸透して完全に除去できず、使用時に薬液あるいは体液
を溶剤汚染するようなことはない。
(2) Effects of the Invention In the present invention, an adhesive whose main component is a volatile solvent such as THF or cyclohexane is not used. Therefore, a portion of this solvent will not penetrate into the constituent materials of the medical device such as vinyl chloride resin and cannot be completely removed, thereby preventing contamination of medical fluids or body fluids with the solvent during use.

」二記のような溶剤を使用しない接着方法として、エポ
キシ樹脂、UV接着剤、ホットメルト等を使用しても、
特に軟質塩化ビニル樹脂については、接着力が弱く、安
全性、作業性の面でも問題があった。 本発明によれば
、十分な接着強度が得られ、また、接着後に接着部分の
べとつきもなく、安全性、作業性の面でも問題はない。
Even if you use epoxy resin, UV adhesive, hot melt, etc. as a bonding method that does not use solvents as described in 2.
In particular, soft vinyl chloride resin has weak adhesive strength and has problems in terms of safety and workability. According to the present invention, sufficient adhesive strength can be obtained, and there is no stickiness at the bonded portion after bonding, so there is no problem in terms of safety and workability.

本発明は、接着部から遠くなる程、可塑剤濃度が低くな
るため、接着部とその他の部分との物性が徐々に変化し
て、急激に変化しないため、外部からの応力に対して力
が分散して接着部における剥離が生じにくいという効果
がある。
In the present invention, the plasticizer concentration decreases as the distance from the bonded area increases, so the physical properties between the bonded area and other parts change gradually and do not change abruptly. It has the effect that it is dispersed and peeling at the adhesive part is less likely to occur.

本発明で用いる接着剤は、不揮発性の可塑剤に対して少
量の(0,5〜lO重量部)塩化ビニル樹脂を加熱溶解
せしめるだけで調整でき、また冷却して保存も可能であ
る。従来のベーストレジンは塩化ビニル樹脂の含有量も
高く、取扱上も問題があるが、本発明の接着剤は取扱上
も簡易である。
The adhesive used in the present invention can be prepared by simply heating and dissolving a small amount (0.5 to 10 parts by weight) of vinyl chloride resin in a nonvolatile plasticizer, and can also be stored by cooling. Conventional base resins have a high content of vinyl chloride resin and are problematic in handling, but the adhesive of the present invention is easy to handle.

本発明に用いる接着剤では、必要な接着強度が加熱処理
条件(加熱時間)によって選択でき、その加熱処理によ
って接着部が変質するようなこともない。
In the adhesive used in the present invention, the necessary adhesive strength can be selected by the heat treatment conditions (heating time), and the heat treatment does not cause the bonded portion to change in quality.

本発明の接着剤を用いて、加熱処理されて得られる接着
部は、接着剤中の可塑剤が接着すべき部材の材料中に拡
散移行し、接着部自体は接着すべき部材と同様の材料が
残り、接着すべき部材と同質的となって境界がなくなる
。従って、その接着強度も大きくなり、オートクレーブ
滅菌処理後には、接着強度は接着部以外よりも大きくな
る程である。
In the bonded part obtained by heat treatment using the adhesive of the present invention, the plasticizer in the adhesive diffuses into the material of the member to be bonded, and the bonded part itself is made of the same material as the member to be bonded. remains, and becomes homogeneous with the parts to be bonded, with no boundaries. Therefore, the adhesive strength is also increased, and after autoclave sterilization, the adhesive strength is greater than that of other parts.

すなわち接着部を互いに反対方向に引っ張ったときに、
接着部は剥離せず、接着部を除く他の部分が破断してし
まう程の接着力が得られる。
In other words, when the adhesive parts are pulled in opposite directions,
The bonded portion does not peel off, and the adhesive strength is strong enough to cause the other portions other than the bonded portion to break.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、本発明の医療用具の製造工程を示−14図、
第2図は本発明方法により製造される血液バッグの接着
部の一例を示す平面図、第3図は第2図の接着部の部分
断面図、第4図は本発明の接着剤の好適塗布温度を示す
グラフ、第5図および第6図はカバーチューブの接着性
を示すグラフ、第7図および第8図は7字管の接着性を
示すグラフである。 〔符合の説明〕 1.3・・・チューブ、2・・・接着剤、4・・・接続
部。 10・・・採血チューブ、 11 胃カバーチューブ。 12・・・連結チューブ、13・・・Y字管FIG、2 FIG、3 (a)   i。 FIG、4 FIG、5 FIG、6 FIG、7 FIG、8
Figure 1 shows the manufacturing process of the medical device of the present invention - Figure 14;
FIG. 2 is a plan view showing an example of the bonded portion of a blood bag manufactured by the method of the present invention, FIG. 3 is a partial sectional view of the bonded portion of FIG. 2, and FIG. 4 is a preferred application of the adhesive of the present invention. Graphs showing the temperature, FIGS. 5 and 6 are graphs showing the adhesion of the cover tube, and FIGS. 7 and 8 are graphs showing the adhesion of the 7-shaped tube. [Explanation of symbols] 1.3...Tube, 2...Adhesive, 4...Connection part. 10...Blood collection tube, 11 Stomach cover tube. 12... Connecting tube, 13... Y-shaped tube FIG, 2 FIG, 3 (a) i. FIG, 4 FIG, 5 FIG, 6 FIG, 7 FIG, 8

Claims (3)

【特許請求の範囲】[Claims] (1)少なくとも1つの接着部を有する可塑剤移行性材
料製具であって、該可塑剤移行性材料製具中の可塑剤濃
度が勾配を示し、その濃度は接着部から遠くなる程、低
いことを特徴とする可塑剤移行性材料製具。
(1) A plasticizer-migration material tool having at least one bonded portion, wherein the plasticizer concentration in the plasticizer-migration material tool exhibits a gradient, and the concentration is lower as the distance from the bonded portion increases. A plasticizer migration material tool characterized by:
(2)少なくとも1つの接続部を有し、該可塑剤移行性
材料製具中の可塑剤濃度が勾配を示し、その濃度は接着
部から遠くなる程、低いものである可塑剤移行性材料製
具を製造するに際し、接着すべき部分間に可塑剤100
重量部中に、0.5〜10重量部の塩化ビニル樹脂を溶
解してなる接着剤を介在さしめ、該接着剤を硬化させて
接着することを特徴とする可塑剤移行性材料製具の製造
方法。
(2) Made of a plasticizer-migrating material having at least one connection part, in which the plasticizer concentration in the plasticizer-migrating material device exhibits a gradient, and the concentration decreases as the distance from the bonding part increases. When manufacturing the tool, add 100% plasticizer between the parts to be bonded.
A plasticizer migration material product characterized by interposing an adhesive formed by dissolving 0.5 to 10 parts by weight of vinyl chloride resin in parts by weight, and curing the adhesive to bond the product. Production method.
(3)接着剤を加熱処理して硬化させる特許請求の範囲
第2項に記載の可塑剤移行性材料製具の製造方法。
(3) The method for manufacturing a plasticizer transferable material tool according to claim 2, wherein the adhesive is cured by heat treatment.
JP16133284A 1984-07-31 1984-07-31 Instrument made of plasticizer migration material and its production Granted JPS6137247A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16133284A JPS6137247A (en) 1984-07-31 1984-07-31 Instrument made of plasticizer migration material and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16133284A JPS6137247A (en) 1984-07-31 1984-07-31 Instrument made of plasticizer migration material and its production

Publications (2)

Publication Number Publication Date
JPS6137247A true JPS6137247A (en) 1986-02-22
JPH044939B2 JPH044939B2 (en) 1992-01-29

Family

ID=15733068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16133284A Granted JPS6137247A (en) 1984-07-31 1984-07-31 Instrument made of plasticizer migration material and its production

Country Status (1)

Country Link
JP (1) JPS6137247A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01135839A (en) * 1987-11-20 1989-05-29 Terumo Corp Production of vinyl chloride resin product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49120935A (en) * 1973-03-22 1974-11-19
JPS5181829A (en) * 1975-01-13 1976-07-17 Miura Kumihimo Kojo Kk SETSUCHAKUZA ISOSEIBUTSU

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49120935A (en) * 1973-03-22 1974-11-19
JPS5181829A (en) * 1975-01-13 1976-07-17 Miura Kumihimo Kojo Kk SETSUCHAKUZA ISOSEIBUTSU

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01135839A (en) * 1987-11-20 1989-05-29 Terumo Corp Production of vinyl chloride resin product
JPH0566854B2 (en) * 1987-11-20 1993-09-22 Terumo Corp

Also Published As

Publication number Publication date
JPH044939B2 (en) 1992-01-29

Similar Documents

Publication Publication Date Title
US4627844A (en) Tri-layer tubing
DE69627715T2 (en) A THERMOSTATOPLASTIC PRECURSOR FOR A PRESSURE-SENSITIVE ADHESIVE
US4687474A (en) Junction for medical instruments
EP0074218B1 (en) Heat recoverable article
US4168192A (en) Process for making recoverable tubular article
JPS6137247A (en) Instrument made of plasticizer migration material and its production
JPS59164116A (en) Curing sheet
US6649681B2 (en) Adhesive composition primarily intended for use in medical applications
JPH0137956B2 (en)
US5135600A (en) Method for producing vinyl chloride resin products
JPH0432707B2 (en)
JP2003147323A (en) Adhesive composition, adhesive film, semiconductor carrier member, and semiconductor device and its production method
JP3102921B2 (en) Medical device and method of manufacturing medical device
JPH0158990B2 (en)
JPS59187067A (en) Adhesive for rigid vinyl chloride resin
JPH0280059A (en) Synthetic resin-made assembly unit and manufacture thereof
JPS60197784A (en) Water-swellable composition and water-stopping molding made thereof
JP3325289B2 (en) Thermosetting adhesive composition, synthetic resin-lined tube, and method for producing synthetic resin-lined tube
JP4577545B2 (en) MEDICAL LINKAGE AND ITS MANUFACTURING METHOD
JPH0582247B2 (en)
JPH01151464A (en) Manufacture of medical device
SU176346A1 (en) METHOD OF GLUING OPTICAL PARTS
JPH0718240A (en) Adhesive
JPS62252491A (en) Epoxy resin thermosetting adhesive
JPS5968210A (en) Thermally recoverable article

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term